Zotefoams : Preliminary 2014 results presentation

ZOTEFOAMS plc

Zotefoams plc

Preliminary Results Presentation

March 2015

David Stirling : Managing Director

Clifford Hurst : Finance Director

HighlightsIn Constant FX:

• Total Revenue1 increased by 15%

• High-Performance Products ('HPP') revenue growth of 61%

• Profit before tax and exceptional items2 up 43%

Other:

• HPP segment margins increase to 15% (2013: 6%)

• MuCell Extrusion LLC ('MEL') installed equipment base increases by 62% to 52 units (2013: 32)

• Successful share placing in September 2014 raising £8.8m gross to deliver global capacity expansion based at Group's Kentucky, USA site

• Proposed final dividend increased by 3% to 3.7 pence (2013: 3.6p)

1 Total Revenue consolidates all external sales made by the joint ventures as well as those made by Zotefoams plc and its subsidiaries.

2 The non-cash impairment charge made following the decision to curtail manufacturing activity on the microZOTE® extrusion line has been treated as an exceptional item.

Constant FX : calculated by restating 2014 at 2013 average foreign currency exchange rates but excluding Balance Sheet translation differences (see Press Statement) .